Alkermes, Inc. (NASDAQ:ALKS)

CAPS Rating: 4 out of 5

A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.

Recs

0
Player Avatar SamTheRich (80.53) Submitted: 4/6/2009 1:23:48 AM : Outperform Start Price: $9.39 ALKS Score: +9.19

goooooooood

Featured Broker Partners


Advertisement